These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8447559)

  • 1. Biology of graft-vs.-host disease.
    Korngold R
    Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):18-27. PubMed ID: 8447559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens.
    Berger M; Wettstein PJ; Korngold R
    Transplantation; 1994 Apr; 57(7):1095-102. PubMed ID: 7909395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lethal graft-versus-host disease in mice directed to multiple minor histocompatibility antigens: features of CD8+ and CD4+ T cell responses.
    Korngold R
    Bone Marrow Transplant; 1992 May; 9(5):355-64. PubMed ID: 1352163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter-strain graft-vs.-host disease T-cell responses to immunodominant minor histocompatibility antigens.
    Korngold R; Leighton C; Mobraaten LE; Berger MA
    Biol Blood Marrow Transplant; 1997 Jun; 3(2):57-64. PubMed ID: 9267665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of graft-versus-host disease directed to minor histocompatibility antigens.
    Korngold R
    Bone Marrow Transplant; 1991; 7 Suppl 1():38-41. PubMed ID: 2043884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of immunodominance among minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation.
    Mori S; El-Baki H; Mullen CA
    Bone Marrow Transplant; 2003 May; 31(10):865-75. PubMed ID: 12748663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease.
    Zhang Y; Joe G; Hexner E; Zhu J; Emerson SG
    J Immunol; 2005 Mar; 174(5):3051-8. PubMed ID: 15728519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chloroquine treatment affects T-cell priming to minor histocompatibility antigens and graft-versus-host disease.
    Schultz KR; Bader S; Paquet J; Li W
    Blood; 1995 Dec; 86(11):4344-52. PubMed ID: 7492796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens.
    Jones SC; Friedman TM; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):91-105. PubMed ID: 14750075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-time T-cell profiling identifies H60 as a major minor histocompatibility antigen in murine graft-versus-host disease.
    Choi EY; Christianson GJ; Yoshimura Y; Jung N; Sproule TJ; Malarkannan S; Joyce S; Roopenian DC
    Blood; 2002 Dec; 100(13):4259-65. PubMed ID: 12393464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ but not CD4+ T cells require cognate interactions with target tissues to mediate GVHD across only minor H antigens, whereas both CD4+ and CD8+ T cells require direct leukemic contact to mediate GVL.
    Matte-Martone C; Liu J; Jain D; McNiff J; Shlomchik WD
    Blood; 2008 Apr; 111(7):3884-92. PubMed ID: 18223170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral tolerance to host minor histocompatibility antigens in radiation bone marrow chimeras abrogates lethal GVHD while preserving GVL effect.
    de la Selle V; Miconnet I; Gilbert D; Bruley-Rosset M
    Bone Marrow Transplant; 1995 Jul; 16(1):111-8. PubMed ID: 7581109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of lethal graft-versus-host disease following allogeneic bone marrow transplantation in mice by short course administration of LF 08-0299.
    Annat J; Churaqui E; Dutartre P; Bruley-Rosset M
    Transplantation; 1996 Sep; 62(6):721-9. PubMed ID: 8824467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft-versus-host disease in experimental allogeneic bone marrow transplantation.
    Korngold R; Sprent J
    Proc Soc Exp Biol Med; 1991 May; 197(1):12-8. PubMed ID: 2020668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.
    Johnson BD; Becker EE; Truitt RL
    Biol Blood Marrow Transplant; 1999; 5(3):123-32. PubMed ID: 10392958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of in vitro cytotoxic T lymphocyte assays as a predictive test for the occurrence of graft vs host disease.
    Fontaine P; Langlais J; Perreault C
    Immunogenetics; 1991; 34(4):222-6. PubMed ID: 1916950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor T cells lacking Fas ligand and perforin retain the capacity to induce severe GvHD in minor histocompatibility antigen mismatched bone-marrow transplantation recipients.
    Marks L; Altman NH; Podack ER; Levy RB
    Transplantation; 2004 Mar; 77(6):804-12. PubMed ID: 15077018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of responding CD4+ and CD8+ T-cell repertoires during the development of graft-versus-host disease directed to minor histocompatibility antigens.
    Friedman TM; Jones SC; Statton D; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2004 Apr; 10(4):224-35. PubMed ID: 15077221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.